These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28819771)

  • 21. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation.
    Obed A; Beham A; Püllmann K; Becker H; Schlitt HJ; Lorf T
    World J Gastroenterol; 2007 Feb; 13(5):761-7. PubMed ID: 17278200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database.
    Sarwar A; Bonder A; Hassan L; Malik MS; Novack V; Curry M; Ahmed M
    AJR Am J Roentgenol; 2023 May; 220(5):727-735. PubMed ID: 36475810
    [No Abstract]   [Full Text] [Related]  

  • 25. Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times.
    Eswaran SL; Pierce K; Weaver F; Rogers T; Brems JJ; Sontag SJ; Borge M
    Angiology; 2012 Apr; 63(3):206-12. PubMed ID: 21733955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Neoadjuvant Transcatheter Arterial Chemoembolization and Orthotopic Liver Transplantation for the Treatment of Cirrhotomimetic Hepatocellular Carcinoma.
    Habibollahi P; Shamchi SP; Tondon R; Ecker BL; Gade TP; Hunt S; Soulen MC; Furth EE; Levine MH; Nadolski G
    J Vasc Interv Radiol; 2018 Feb; 29(2):237-243. PubMed ID: 29221923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.
    Zori AG; Ismael MN; Limaye AR; Firpi R; Morelli G; Soldevila-Pico C; Suman A; Vogel JD; Lazarowicz M; Geller BS; Toskich B; Gonzalo DH; Johnson MW; Cabrera R
    Am J Clin Oncol; 2020 May; 43(5):325-333. PubMed ID: 32079854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
    Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
    Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
    Schaudt A; Kriener S; Schwarz W; Wullstein C; Zangos S; Vogl T; Mehrabi A; Fonouni H; Bechstein WO; Golling M
    Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.
    Terzi E; Ray Kim W; Sanchez W; Charlton MR; Schmeltzer P; Gores GJ; Andrews JC; Smyrk TC; Heimbach JK
    Liver Transpl; 2015 Feb; 21(2):248-57. PubMed ID: 25371111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response.
    Frenette CT; Osorio RC; Stark J; Fok B; Boktour MR; Guy J; Rhee J; Osorio RW
    Transplantation; 2014 Oct; 98(7):781-7. PubMed ID: 24825513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.
    Fisher RA; Maroney TP; Fulcher AS; Maluf D; Clay JA; Wolfe LG; Dawson S; Cotterell A; Stravitz RT; Luketic VA; Shiffman M; Sterling RK; Posner MP
    Clin Transplant; 2002; 16 Suppl 7():52-8. PubMed ID: 12372045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of bridge therapy prior to orthotopic liver transplantation.
    Prasad MA; Kulik LM
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1183-90; quiz 1191. PubMed ID: 25099448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma.
    Oligane HC; Close ON; Xing M; Kim HS
    Transplant Rev (Orlando); 2017 Apr; 31(2):136-143. PubMed ID: 28214240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation.
    Ashoori N; Bamberg F; Paprottka P; Rentsch M; Kolligs FT; Siegert S; Peporte A; Al-Tubaikh JA; D'Anastasi M; Hoffmann RT; Reiser MF; Jakobs TF
    Digestion; 2012; 86(4):338-48. PubMed ID: 23207185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study.
    Habibollahi P; Shamchi SP; Choi JM; Gade TP; Stavropoulos SW; Hunt SJ; Dagli M; Sudheendra D; Mondschein JI; Soulen MC; Nadolski GJ
    J Vasc Interv Radiol; 2019 Mar; 30(3):323-329. PubMed ID: 30819472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.